Buformin hydrochloride

CAS: 1190-53-0

Ref. 3D-FB19350

Produktinformation

• Name: Buformin hydrochloride
• Synonyme: N-Butylimidodicarbonimidic diamide hydrochloride1-Butylbiguanide hydrochloride
• Marke: Biosynth
• Beschreibung: Buformin hydrochloride is an oral hypoglycemic drug that belongs to the group of biguanides. It is used for the treatment of type 2 diabetes mellitus and has been shown to have a hypoglycemic effect in patients with breast cancer. The mechanism of action of buformin hydrochloride is not fully understood, but it may involve the regulation of mitochondrial membrane potential and transcription activators. Buformin hydrochloride has been shown to decrease the number of lymphocytes, which are responsible for immune responses. This drug also inhibits the growth of c. glabrata, an opportunistic fungal pathogen, by disrupting energy metabolism. Buformin hydrochloride is metabolized in humans and animals by glucuronidation or sulfation. In analytical studies, benzalkonium chloride (BAK) was used as a crystalline cellulose carrier to increase solubility and stability.

Chemische Eigenschaften

• Molekulargewicht: 193.68 g/mol
• Formel: C₆H₁₆ClN₅
• Reinheit: Min. 95%
• Farbe/Form: White Powder